Boothbay Fund Management, LLC Crispr Therapeutics Ag Put Options Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $4.43 Million - $8.29 Million	114,800 Added 256.82%	159,500 $9.98 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $177,021 - $230,100	3,900 Added 9.56%	44,700 $2.03 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $1.77 Million - $2.77 Million	40,800 New	40,800 $2.29 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $1.39 Million - $2.21 Million	-19,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $297,540 - $422,927	-2,700 Reduced 11.95%	19,900 $2.23 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $2.28 Million - $3.66 Million	22,600 New	22,600 $3.66 Million

523

58M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.